HRH Princess Dina Mired: In Memoriam of My Dear Friend Navid Madani
ADAURA at WCLC 2026: 8-Year Survival Confirms Durable Benefit of Adjuvant Osimertinib in Resected EGFR-Mutated NSCLC
FDA Grants Breakthrough Therapy Designation to Daraxonrasib Plus Chemotherapy in First-Line Metastatic Pancreatic Cancer
Katy Beckermann: New Meta-Analysis Highlights the Importance of FGFR3 Testing
Breast Cancer Brain Metastases Harbor Actionable Genomic Alterations: Could the Brain Lesion Become a Precision-Oncology Target?
STAMINA Trial: Lifestyle Intervention Mitigates ADT-Associated Adverse Effects in Prostate Cancer
OncoDaily Senior Vice President Shushan Hovsepyan Named Candidate for UICC Board of Directors 2026–2028
MATTERHORN: Durvalumab Plus FLOT Improves OS in Resectable Gastric and GEJ Adenocarcinoma
